USPTO serial 97830057
APEXNK
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- TWOHIG, SHANNON MARIE
- Law office
- TMO LAW OFFICE 121
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with APEXNK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph A. Bruce
Joseph A. Bruce BRUCE STONE LLP8888 KEYSTONE CROSSING, SUITE 1300INDIANAPOLIS, IN 46240United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Immunostimulants; Pre-filled cell-based medicinal products, namely, medicinal products for aging, oncology and autoimmune disease; Biological tissue cultures for medical purposes; Anti-cancer preparations; Medicines for the treatment of cancer; Active pharmaceutical ingredient for western medicine, namely, pharmaceutical agents for aging, oncology and autoimmune disease; Anti-cancer agents; Antivirals; Biological preparations for the treatment of cancer; Biocides; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment; Blood for medical purposes; Adjuvants for medical purposes; Albuminous preparations for medical purposes; Pharmaceuticals, namely, immunotherapy being immunostimulators; Pharmaceutical preparations for the treatment of cancer; Stem cells for medical purposes; Reagents for medical use; Diagnostic reagents for medical use | ACTIVE | — |
| 042 | Biological research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others; Research and development in the pharmaceutical and biotechnology fields; Medical research services; Medical research and development in the field of cancer immunotherapy; Research and development of new products for others; Technological research in the field of cancer immunotherapy; Conducting technical project studies in the nature of scientific feasibility studies; Technical writing for others; Scientific laboratory services; Scientific research; Technological consultancy services in the field of cancer immunotherapy; Scientific and technological research relating to cancer immunotherapy; Culturing of cells for others for scientific research purposes; New product design services; Packaging design; Graphic design services; Custom design of prototypes; Graphic design of logos; Quality control of goods and services; Product quality testing services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 8, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 8, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 7, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 7, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 24, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 24, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 23, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 23, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 15, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 15, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 14, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 21, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 21, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 21, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 21, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 21, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 21, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 4, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 2, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 2, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 13, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 28, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 21, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 21, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 7, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 13, 2023 | NWAP | NEW APPLICATION ENTERED | — |